Independent research on the U.S. markets, Baptista Research

Baptista Research

Independent research on the U.S. markets

Baptista Research is an independent financial research house focused on the U.S. markets. We provide equity research as well as credit research reports on the top-listed U.S. companies with most of our focus on technology, consumer goods and services, automobiles, industrials, oil and gas, pharma, and healthcare. Our research has served more than 3000 institutional investors including mutual funds, hedge funds, banks, family offices, and various buy-side firms. We operate a research subscription service where institutions, as well as retail investors, can have priority access to all our research. We also have a wide distribution of our research reports across some of the top global financial platforms. Apart from equity research and credit research, we also provide advisory services with respect to mergers & acquisitions (M&A), private equity/ venture capital fundraising, valuation reports, and investment management services for corporates.
Baptista Research is owned and managed by Ishan Majumdar, an ex-Venture Capitalist/ Investment Banker, a Chartered Accountant, and a Masters’ degree holder in Management from HEC Paris. Ishan has nearly a decade of experience in Mergers and Acquisitions, Leveraged Buyouts (LBOs), Venture Capital Investing, Corporate Strategy, and Valuation in front-office roles at the likes of BNP Paribas CIB, Credit Agricole CIB, Groupe Danone, and TIW Private Equity. He has worked on and closed multiple acquisition deals, leveraged buyouts, and start-up investment transactions.

Equity Bottom-Up

<ul><li>Ingersoll Rand reported its second quarter and first half of 2026 results with continued execution strength and improving demand across its diverse markets.</li><li>The company achieved 2% organic order growth and 4% organic revenue growth in the quarter, driving a 7% adjusted EPS increase year-over-year.</li><li>Growth was broad-based, with every major region delivering positive organic revenue growth, and strong momentum was seen particularly in short- to medium-cycle businesses.</li></ul>

Ingersoll Rand reported its second quarter and first half of 2026 results with continued execution strength and improving demand across its diverse markets.The company achieved 2% organic order growth and 4% organic revenue growth in the quarter, driving a 7% adjusted EPS increase year-over-year.Growth was broad-based, with every major region delivering positive organic revenue growth, and strong momentum was seen particularly in short- to medium-cycle businesses.

Ingersoll Rand Adds Lone Star Blowers & Fai Filtri — Aftermarket Growth Gets Another Boost!

<ul><li>Ingersoll Rand has continued to position acquisitions as a central pillar of its growth strategy, and its planned acquisition of Fox s.r.l. fits neatly into that playbook.</li><li>The company recently highlighted Fox as a signed transaction expected to close around the end of April 2026, adding a Milan-based manufacturer of hydropneumatic accumulators, pulsation dampeners, calibration pots, and related instrumentation.</li><li>Fox will join Ingersoll Rand’s Precision and Science Technologies segment, where management has been building out higher-value technologies and adjacencies.</li></ul>

Ingersoll Rand has continued to position acquisitions as a central pillar of its growth strategy, and its planned acquisition of Fox s.r.l. fits neatly into that playbook.The company recently highlighted Fox as a signed transaction expected to close around the end of April 2026, adding a Milan-based manufacturer of hydropneumatic accumulators, pulsation dampeners, calibration pots, and related instrumentation.Fox will join Ingersoll Rand’s Precision and Science Technologies segment, where management has been building out higher-value technologies and adjacencies.

Ingersoll Rand Acquisition Strategy Just Got More Aggressive With Fox Deal!

<ul><li>Ingersoll Rand’s first quarter of 2026 reflected a steady start amid a complex global environment.</li><li>The company reported adjusted earnings per share growth of 7%, reaching $0.77, with revenue and adjusted EBITDA aligning with expectations.</li><li>Total revenue increased 8% year-over-year, supported by a 5% rise in orders, although organic order growth was approximately flat when excluding a $40 million delay caused by geopolitical tension in the Middle East.</li></ul>

Ingersoll Rand’s first quarter of 2026 reflected a steady start amid a complex global environment.The company reported adjusted earnings per share growth of 7%, reaching $0.77, with revenue and adjusted EBITDA aligning with expectations.Total revenue increased 8% year-over-year, supported by a 5% rise in orders, although organic order growth was approximately flat when excluding a $40 million delay caused by geopolitical tension in the Middle East.

Ingersoll Rand: From Compressor Savings to Life Sciences Expansion—What’s Fueling the Momentum?

<ul><li>Ingersoll Rand's fourth-quarter earnings call for 2025 provides insights into the company's financial performance and strategic direction.</li><li>The company reported steady growth with low single-digit organic order growth both for the quarter and the year, alongside an optimistic outlook for 2026.</li><li>This performance signals resilience in their recurring revenue initiatives and disciplined mergers and acquisitions (M&A) strategy.</li></ul>

Ingersoll Rand's fourth-quarter earnings call for 2025 provides insights into the company's financial performance and strategic direction.The company reported steady growth with low single-digit organic order growth both for the quarter and the year, alongside an optimistic outlook for 2026.This performance signals resilience in their recurring revenue initiatives and disciplined mergers and acquisitions (M&A) strategy.

<ul><li>Ingersoll Rand has been busy sharpening its M&A strategy throughout 2025, executing 14 bolt-on acquisitions and signaling no slowdown with nine more under LOI.</li><li>In the latest of these strategic moves, the company announced its acquisition of Scinomix, a U.S.-based life sciences automation firm.</li><li>Known for its specialization in labeling, handling, barcode scanning, and capping solutions, Scinomix serves a wide array of end-markets, including clinical, pharmaceutical, biotechnology, forensic, agricultural, and genetic testing labs.</li></ul>

Ingersoll Rand has been busy sharpening its M&A strategy throughout 2025, executing 14 bolt-on acquisitions and signaling no slowdown with nine more under LOI.In the latest of these strategic moves, the company announced its acquisition of Scinomix, a U.S.-based life sciences automation firm.Known for its specialization in labeling, handling, barcode scanning, and capping solutions, Scinomix serves a wide array of end-markets, including clinical, pharmaceutical, biotechnology, forensic, agricultural, and genetic testing labs.

Ingersoll Rand Acquires Scinomix—Is A Life Sciences Pivot Underway?

United States

Ingersoll Rand Inc. manufactures flow control equipment. The Company offers vacuum systems, bottle blowers, pumps, and air and gas compressors. Ingersoll-Rand serves customers worldwide.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Ingersoll Rand (IR US)

Ingersoll Rand Adds Lone Star Blowers & Fai Filtri — Aftermarket Growth Gets Another Boost!

Ingersoll Rand reported its second quarter and first half of 2026 results with continued execution strength and improving demand across its...

Baptista Research

Ingersoll Rand Acquisition Strategy Just Got More Aggressive With Fox Deal!

Ingersoll Rand has continued to position acquisitions as a central pillar of its growth strategy, and its planned acquisition of Fox s.r.l. fits...

Baptista Research

Ingersoll Rand: From Compressor Savings to Life Sciences Expansion—What’s Fueling the Momentum?

Ingersoll Rand’s first quarter of 2026 reflected a steady start amid a complex global environment. The company reported adjusted earnings per...

Baptista Research

Ingersoll Rand Is Aligning Services

Ingersoll Rand's fourth-quarter earnings call for 2025 provides insights into the company's financial performance and strategic direction. The...

Baptista Research

Ingersoll Rand Acquires Scinomix—Is A Life Sciences Pivot Underway?

Ingersoll Rand has been busy sharpening its M&A strategy throughout 2025, executing 14 bolt-on acquisitions and signaling no slowdown with...

Baptista Research

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)